Noninvasive Detection of Lung Nodule Malignancy Using cfDNA Fragmentomics
NCT07399210 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 240
Last updated 2026-02-10
Summary
The goal of this observational study is to learn if cfDNA fragmentomics can noninvasively diagnose whether lung nodules are benign or malignant in adults with imaging-detected lung nodules.
Conditions
- Lung Cancer (Diagnosis)
- Fragmentomics
Interventions
- OTHER
-
This study did not include intervention between two cohorts
This study did not include intervention between two cohorts
Sponsors & Collaborators
-
Baohui Han
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-08-21
- Primary Completion
- 2026-08-21
- Completion
- 2026-08-21
Countries
- China
Study Locations
More Related Trials
-
Clinical Study of ctDNA and Exosome Combined Detection to Identify Benign and Malignant Pulmonary Nodules
NCT04182893 ·Status: UNKNOWN
-
Multi-omics Detection Techniques for Differentiating Benign and Malignant Pulmonary Nodules
NCT07047573 ·Status: RECRUITING
-
Non-Invasive ctDNA Methylation Detection for Lung Nodule Patients
NCT03685669 ·Status: UNKNOWN
-
Differentiation of Benign and Malignant Pulmonary Nodules by Volatile Organic Compounds in Human Exhaled Breath
NCT06518655 ·Status: RECRUITING
-
SERS-Based Serum Molecular Spectral Screening for Benign and Malignant Pulmonary Proliferative Nodules
NCT06775587 ·Status: NOT_YET_RECRUITING
-
A Multi-modal Integrating Imaging and Cell-free DNA Methylation in Lung Cancer Early Detection (CMe-Lung): a Multi-center, Observational Study
NCT07375979 ·Status: NOT_YET_RECRUITING
-
Identification of a Plasma Proteomic Signature for Lung Cancer
NCT01752101 ·Status: COMPLETED
-
The MDA Test to Differentiate of Benign and Malignant Pulmonary Nodules
NCT03790735 ·Status: UNKNOWN
-
A Prospective Cohort Study of Chinese Patients With Pulmonary Nodules: Prediction of Lung Cancer Using Noninvasive Biomarkers
NCT04462185 ·Status: UNKNOWN
-
Early Diagnosis of Small Pulmonary Nodules by Multi-omics Sequencing
NCT03320044 ·Status: COMPLETED
-
DNA Methylation Combined With Artificial Intelligence Imaging to Identify Lung Nodules
NCT06220305 ·Status: RECRUITING
-
Monitoring the Changes of Tumor-related Biomarkers Before and After Pulmonary Nodule Biopsy.
NCT03397355 ·Status: UNKNOWN
-
Epigenetic Nucleosomes in Plasma for Pulmonary Nodule Differentiation
NCT06838806 ·Status: RECRUITING
-
Constructing a Predictive Model for Differentiating Between Benign and Malignant Solid Pulmonary Nodules Based on Clinical and Imaging Features.
NCT06685458 ·Status: NOT_YET_RECRUITING
-
Construction and Evaluation of the Liquid Biopsy-based Early Diagnostic Model for Lung Cancer
NCT04156360 ·Status: UNKNOWN
-
Low-dose Computed Tomography-guided Core Needle Biopsy for Lung Nodules
NCT04217655 ·Status: COMPLETED ·Phase: NA
-
Low-dose Protocol for Computed Tomography-guided Lung Biopsy
NCT02971176 ·Status: COMPLETED ·Phase: NA
-
Deep Learning Model for Pure Solid Nodules Classification
NCT05542992 ·Status: UNKNOWN
-
The Accuracy of Targeted Lymph Node Dissection of Non-small Cell Lung Cancer Patients According to Predictive Models
NCT06768853 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Predicting Non-small Cell Lung Cancer (NSCLC) Lymph Node Metastasis: Integrating Circulating Tumor DNA (ctDNA) Mutation/ Methylation Profiling With Positron Emission Tomography-computed Tomography (PET-CT) Scan
NCT06358222 ·Status: RECRUITING
-
Biomarkers for Diagnosis of Lung Cancer
NCT02050100 ·Status: COMPLETED
-
Early Stage Lung Cancer Screening With Low-dose Computed Tomographic
NCT02898441 ·Status: UNKNOWN ·Phase: NA
-
Diagnostic and Monitoring Significance of ctDNA Methylation Analysis by NGS in Benign and Malignant Pulmonary Nodules
NCT03651986 ·Status: UNKNOWN
-
A Multicenter Clinical Trial of Sputum DNA Testing for Lung Cancer in China
NCT05337163 ·Status: COMPLETED
-
Liquid Biopsy for Early Non-small Lung Cancer Detection
NCT05462795 ·Status: COMPLETED